The global lymphoma treatment market size is predicted to reach USD 13.11 billion by 2026, exhibiting a CAGR of 8.3% during the forecast period. The increasing R&D investments for strong pipeline candidates by prominent players will contribute positively to the lymphoma treatment marketrevenue in the forthcoming years. For instance, Agios Pharmaceuticals, Inc. announced its clinical trial Phase I for a pipeline candidate called AG-636. The new drug will be used to treat indications of lymphoma. The growing concentration on oncology therapeutics owing to the rising cases of lymphoma in individuals will enable healthy growth of the market in the forthcoming years. According to the published report by Fortune Business Insights, titled “Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (Non-HodgkinLymphoma, and HodgkinLymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies& Drug Stores, and Online Pharmacies), and Regional Forecast, 2019-2026” the market size stood at USD 6.94 billion in 2018.
Request a Sample Copy of the Research Report:
The report covers :
o Global Lymphoma Treatment Market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast timeframe.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.
An Overview of the Impact of COVID-19 on this Market :
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
Leading Players operating in the Lymphoma Treatment Market are :
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Takeda Pharmaceutical Company Limited
- Bayer AG
- Novartis AG
- Kite Pharma, Inc. / Gilead Sciences, Inc.
- Spectrum Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd.
- Bristol Myers Squibb Company
- Janssen Pharmaceuticals, Inc.
Rising Cases of Blood Cancer to Spur Market Opportunities
The increasing prevalence of cancers of different forms, including blood cancer will aid the lymphoma treatment marketgrowth during the forecast period. The growing necessity for advanced and effective therapeutics can be a crucial factor in boosting the lymphoma treatment markettrends. For instance, lymphomas usually have no to minimal symptoms till the cancer hits the last stage and, in that period, an aggressive and efficient therapeutics is required for better clinical outcomes. Furthermore, the requirement for pretreatment options to administer advanced therapeutics in patients for the treatment of lymphoma will enable healthy growth of the market in the foreseeable future. In addition, the demand for enhanced and better clinical outcomes for patients will create business opportunities for this marketduring the forecast period.
Adoption of Advanced Therapeutics to Augment Growth in North America
The lymphoma treatment market in North America stood at USD 3.33 billion in 2018 and is predicted to remain dominant during the forecast period. The growing in the region is attributed to higher diagnosis and treatment rates for all these types of cancers. The increasing prevalence of lymphoma along with high adoption of advanced therapeutics will enable growth in the region during the forecast period. The rising awareness about new treatment options among patient population further favor growth in the region. In addition, the presence of major clinical stage biopharmaceutical companies along with various drugs in pipeline candidates will aid expansion in North America. The market in Europe and Asia-Pacific is projected to hold significant share in the forthcoming years owing to the new regulatory approvals of key products in the regions. The launch of advanced therapeutics, for instance, Kymriah (tisagenlecleucel) by Novartis AG and is used for the treatment of B‑cell precursor acute lymphoblastic leukemia. The presence of a large patient population along with prevalence of cancer will aid growth in Asia Pacific. However, limited healthcare expenditure of regions such as Latin America and the Middle East will restrict the growth of the market.
Have Any Query? Ask Our Experts :
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Linkedin | Twitter | BLogs
Related Reports :